KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Asset Utilization Ratio: 2009-2024

Historic Asset Utilization Ratio for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to 0.40.

  • Teva Pharmaceutical Industries' Asset Utilization Ratio rose 3.91% to 0.42 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42, marking a year-over-year increase of 3.91%. This contributed to the annual value of 0.40 for FY2024, which is 10.31% up from last year.
  • According to the latest figures from FY2024, Teva Pharmaceutical Industries' Asset Utilization Ratio is 0.40, which was up 10.31% from 0.36 recorded in FY2023.
  • Teva Pharmaceutical Industries' 5-year Asset Utilization Ratio high stood at 0.40 for FY2024, and its period low was 0.31 during FY2020.
  • Its 3-year average for Asset Utilization Ratio is 0.36, with a median of 0.36 in 2023.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first fell by 0.79% in 2022, then rose by 11.25% in 2023.
  • Over the past 5 years, Teva Pharmaceutical Industries' Asset Utilization Ratio (MRY) stood at 0.31 in 2020, then grew by 4.82% to 0.32 in 2021, then grew by 0.79% to 0.33 in 2022, then increased by 11.25% to 0.36 in 2023, then increased by 10.31% to 0.40 in 2024.
  • Its Asset Utilization Ratio stands at 0.40 for FY2024, versus 0.36 for FY2023 and 0.33 for FY2022.